IDEXX LABORATORIES INC /DE Operating Cash Flow
IDEXX LABORATORIES INC /DE (IDXX) reported Operating Cash Flow of $613.41 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $347.16M, a 86.90% increase year-over-year.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $266.25M, a 11.89% increase year-over-year.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $355.76M, a 35.77% increase year-over-year.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $402.34M, a 82.82% increase year-over-year.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) operating activities for fiscal 2025 was $1.18B, a 27.21% increase from fiscal 2024.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) operating activities for fiscal 2024 was $929.00M, a 2.48% increase from fiscal 2023.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) operating activities for fiscal 2023 was $906.51M, a 66.95% increase from fiscal 2022.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) operating activities for fiscal 2022 was $542.98M, a 28.13% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $347.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $613.41M 10-Q · filed 2026-08-04 | $969.17M derived: sum of 3 quarters · filed 2026-08-04 | $1.37B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $266.25M 10-Q · filed 2026-05-05 | $622.01M derived: sum of 2 quarters · filed 2026-05-05 | $1.02B derived: sum of 3 quarters · filed 2026-05-05 | $1.21B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $355.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $758.10M derived: sum of 2 quarters · filed 2026-02-20 | $943.84M derived: sum of 3 quarters · filed 2026-08-04 | $1.18B 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | $402.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $588.08M derived: sum of 2 quarters · filed 2026-08-04 | $826.04M 10-Q · filed 2025-11-03 | $1.09B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $185.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $423.70M 10-Q · filed 2026-08-04 | $685.73M derived: sum of 3 quarters · filed 2026-08-04 | $905.81M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $237.96M 10-Q · filed 2026-05-05 | $499.99M derived: sum of 2 quarters · filed 2026-05-05 | $720.07M derived: sum of 3 quarters · filed 2026-05-05 | $968.38M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $262.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $482.10M derived: sum of 2 quarters · filed 2026-02-20 | $730.42M derived: sum of 3 quarters · filed 2026-02-20 | $929.00M 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | $220.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $468.39M derived: sum of 2 quarters · filed 2025-11-03 | $666.98M 10-Q · filed 2025-11-03 | $916.83M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-06-30 | $248.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $446.90M 10-Q · filed 2025-08-04 | $696.75M derived: sum of 3 quarters · filed 2026-02-20 | $969.18M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-03-31 | $198.59M 10-Q · filed 2025-05-01 | $448.44M derived: sum of 2 quarters · filed 2026-02-20 | $720.87M derived: sum of 3 quarters · filed 2026-02-20 | $921.18M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2023-12-31 | $249.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $522.28M derived: sum of 2 quarters · filed 2026-02-20 | $722.60M derived: sum of 3 quarters · filed 2026-02-20 | $906.51M 10-K · filed 2026-02-20 | ||||
| 2023-09-30 | $272.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $472.75M derived: sum of 2 quarters · filed 2024-10-31 | $656.66M 10-Q · filed 2024-10-31 | $830.09M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | $200.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $384.23M 10-Q · filed 2024-08-06 | $557.65M derived: sum of 3 quarters · filed 2025-02-21 | $746.65M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | $183.91M 10-Q · filed 2024-05-01 | $357.34M derived: sum of 2 quarters · filed 2025-02-21 | $546.34M derived: sum of 3 quarters · filed 2025-02-21 | $612.19M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | $173.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $362.43M derived: sum of 2 quarters · filed 2025-02-21 | $428.28M derived: sum of 3 quarters · filed 2025-02-21 | $542.98M 10-K · filed 2025-02-21 | ||||
| 2022-09-30 | $189.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $254.85M derived: sum of 2 quarters · filed 2023-11-01 | $369.56M 10-Q · filed 2023-11-01 | $579.52M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $65.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $180.56M 10-Q · filed 2023-08-01 | $390.52M derived: sum of 3 quarters · filed 2024-02-22 | $577.73M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $114.71M 10-Q · filed 2023-05-02 | $324.67M derived: sum of 2 quarters · filed 2024-02-22 | $511.88M derived: sum of 3 quarters · filed 2024-02-22 | $745.83M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $209.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $397.17M derived: sum of 2 quarters · filed 2024-02-22 | $631.12M derived: sum of 3 quarters · filed 2024-02-22 | $755.55M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $187.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $421.16M derived: sum of 2 quarters · filed 2022-11-01 | $545.58M 10-Q · filed 2022-11-01 | $764.52M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-06-30 | $233.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $358.38M 10-Q · filed 2022-08-02 | $577.31M derived: sum of 3 quarters · filed 2023-02-16 | $770.43M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-03-31 | $124.42M 10-Q · filed 2022-05-04 | $343.36M derived: sum of 2 quarters · filed 2023-02-16 | $536.47M derived: sum of 3 quarters · filed 2023-02-16 | $744.61M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2020-12-31 | $218.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $412.05M derived: sum of 2 quarters · filed 2023-02-16 | $620.19M derived: sum of 3 quarters · filed 2023-02-16 | $648.06M 10-K · filed 2023-02-16 | ||||
| 2020-09-30 | $193.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $401.26M derived: sum of 2 quarters · filed 2021-11-02 | $429.13M 10-Q · filed 2021-11-02 | $584.54M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | $208.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $236.01M 10-Q · filed 2021-07-30 | $391.43M derived: sum of 3 quarters · filed 2022-02-16 | $523.69M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | $27.87M 10-Q · filed 2021-05-04 | $183.28M derived: sum of 2 quarters · filed 2022-02-16 | $315.55M derived: sum of 3 quarters · filed 2022-02-16 | $452.65M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | $155.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $287.68M derived: sum of 2 quarters · filed 2022-02-16 | $424.78M derived: sum of 3 quarters · filed 2022-02-16 | $459.16M 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | $132.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $269.37M derived: sum of 2 quarters · filed 2020-10-29 | $303.75M 10-Q · filed 2020-10-29 | $439.39M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | $137.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $171.48M 10-Q · filed 2020-07-31 | $307.13M derived: sum of 3 quarters · filed 2021-02-12 | $417.84M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $34.38M 10-Q · filed 2020-04-30 | $170.03M derived: sum of 2 quarters · filed 2021-02-12 | $280.73M derived: sum of 3 quarters · filed 2021-02-12 | $399.56M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $135.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $246.36M derived: sum of 2 quarters · filed 2021-02-12 | $365.19M derived: sum of 3 quarters · filed 2021-02-12 | $400.08M 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | $110.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $229.54M derived: sum of 2 quarters · filed 2019-10-31 | $264.44M 10-Q · filed 2019-10-31 | $385.56M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-06-30 | $118.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $153.73M 10-Q · filed 2019-08-01 | $274.85M derived: sum of 3 quarters · filed 2020-02-14 | $385.54M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-03-31 | $34.90M 10-Q · filed 2019-05-01 | $156.02M derived: sum of 2 quarters · filed 2020-02-14 | $266.71M derived: sum of 3 quarters · filed 2020-02-14 | $376.90M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2017-12-31 | $121.13M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $231.81M derived: sum of 2 quarters · filed 2020-02-14 | $342.00M derived: sum of 3 quarters · filed 2020-02-14 | $373.28M 10-K · filed 2020-02-14 | ||||
| 2017-09-30 | $110.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $220.88M derived: sum of 2 quarters · filed 2018-11-01 | $252.15M 10-Q · filed 2018-11-01 | |||||
| 2017-06-30 | $110.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $141.47M 10-Q · filed 2018-08-01 | ||||||
| 2017-03-31 | $31.27M 10-Q · filed 2018-05-04 | |||||||
| 2015-06-30 | $80.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $65.52M 10-Q · filed 2015-07-30 | $92.83M derived: sum of 3 quarters · filed 2015-07-30 | $186.09M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2015-03-31 | -$14.64M 10-Q · filed 2015-04-28 | $12.66M derived: sum of 2 quarters · filed 2015-04-28 | $105.92M derived: sum of 3 quarters · filed 2015-04-28 | $187.68M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2014-12-31 | $27.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $120.57M derived: sum of 2 quarters · filed 2015-02-17 | $202.33M derived: sum of 3 quarters · filed 2015-07-30 | $235.85M 10-K · filed 2015-02-17 | ||||
| 2014-09-30 | $93.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $175.03M derived: sum of 2 quarters · filed 2015-07-30 | $208.54M 10-Q · filed 2014-10-24 | $273.96M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2014-06-30 | $81.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $115.28M 10-Q · filed 2015-07-30 | $180.69M derived: sum of 3 quarters · filed 2015-07-30 | $258.79M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2014-03-31 | $33.52M 10-Q · filed 2015-04-28 | $98.93M derived: sum of 2 quarters · filed 2015-04-28 | $177.03M derived: sum of 3 quarters · filed 2015-04-28 | $258.46M derived: sum of 4 quarters · filed 2015-04-28 | ||||
| 2013-12-31 | $65.42M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $143.51M derived: sum of 2 quarters · filed 2015-02-17 | $224.94M derived: sum of 3 quarters · filed 2015-02-17 | $246.00M 10-K · filed 2015-02-17 | ||||
| 2013-09-30 | $78.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $159.53M derived: sum of 2 quarters · filed 2014-10-24 | $180.58M 10-Q · filed 2014-10-24 | $179.73M 10-Q · filed 2013-10-22 | $249.50M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-06-30 | $81.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $102.48M 10-Q · filed 2014-07-25 | $100.00M 10-Q · filed 2013-07-23 | $171.40M derived: sum of 3 quarters · filed 2015-02-17 | $246.09M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-03-31 | $21.05M 10-Q · filed 2014-04-25 | $20.68M 10-Q · filed 2013-04-23 | $89.97M derived: sum of 2 quarters · filed 2015-02-17 | $164.66M derived: sum of 3 quarters · filed 2015-02-17 | $228.28M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2012-12-31 | $68.92M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $143.61M derived: sum of 2 quarters · filed 2015-02-17 | $207.22M derived: sum of 3 quarters · filed 2015-02-17 | $222.41M 10-K · filed 2015-02-17 | $230.28M 10-K · filed 2013-02-19 | |||
| 2012-09-30 | $74.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | $138.30M derived: sum of 2 quarters · filed 2013-10-22 | $153.49M 10-Q · filed 2013-10-22 | $207.88M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2012-06-30 | $63.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-23 | $78.80M 10-Q · filed 2013-07-23 | $133.19M derived: sum of 3 quarters · filed 2014-02-18 | $208.40M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2012-03-31 | $15.18M 10-Q · filed 2013-04-23 | $69.58M derived: sum of 2 quarters · filed 2014-02-18 | $144.79M derived: sum of 3 quarters · filed 2014-02-18 | $207.88M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2011-12-31 | $54.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $129.60M derived: sum of 2 quarters · filed 2014-02-18 | $192.69M derived: sum of 3 quarters · filed 2014-02-18 | $217.91M 10-K · filed 2014-02-18 | $220.70M 10-K · filed 2012-02-17 | |||
| 2011-09-30 | $75.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-19 | $138.30M derived: sum of 2 quarters · filed 2012-10-19 | $163.52M 10-Q · filed 2012-10-19 | $212.37M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2011-06-30 | $63.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-20 | $88.31M 10-Q · filed 2012-07-20 | $137.16M derived: sum of 3 quarters · filed 2013-02-19 | $192.06M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2011-03-31 | $25.22M 10-Q · filed 2012-04-20 | $74.07M derived: sum of 2 quarters · filed 2013-02-19 | $128.97M derived: sum of 3 quarters · filed 2013-02-19 | $184.85M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2010-12-31 | $48.85M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $103.75M derived: sum of 2 quarters · filed 2013-02-19 | $159.63M derived: sum of 3 quarters · filed 2013-02-19 | $178.83M 10-K · filed 2013-02-19 | ||||
| 2010-09-30 | $54.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-21 | $110.78M derived: sum of 2 quarters · filed 2011-10-21 | $129.98M 10-Q · filed 2011-10-21 | $189.43M derived: sum of 4 quarters · filed 2012-02-17 | ||||
| 2010-06-30 | $55.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-22 | $75.08M 10-Q · filed 2011-07-22 | $134.53M derived: sum of 3 quarters · filed 2012-02-17 | $179.16M derived: sum of 4 quarters · filed 2012-02-17 | ||||
| 2010-03-31 | $19.20M 10-Q · filed 2011-04-21 | $78.65M derived: sum of 2 quarters · filed 2012-02-17 | $123.28M derived: sum of 3 quarters · filed 2012-02-17 | |||||
| 2009-12-31 | $59.45M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $104.07M derived: sum of 2 quarters · filed 2012-02-17 | $174.95M 10-K · filed 2012-02-17 | |||||
| 2009-09-30 | $44.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-22 | $115.50M 10-Q · filed 2010-10-22 | ||||||
| 2009-06-30 | $70.88M 10-Q · filed 2010-07-23 | |||||||
| 2008-12-31 | $143.31M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |